UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorpo ...

If, before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy or insolvency petition or an involuntary bankruptcy or insolvency petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced. If, before distributing the proceeds in the trust account to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of inc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorpor ...

Financial Performance - For the three months ended March 31, 2023, the company reported a net income of $2,801,083, which included general and administrative expenses of $181,930 and income from investments in the Trust Account of $3,767,513 [101]. - The company has not engaged in any operations or generated revenues to date, relying solely on non-operating income from interest [100]. Liquidity and Financial Position - The company had cash of $3,452 and working capital of $37,413 as of March 31, 2023, indicating limited liquidity [103]. - There is substantial doubt about the company's ability to continue as a going concern for one year from the filing date, as it will need to finance transaction costs for a business combination [104]. Expenses and Future Outlook - The company expects to incur significantly increased expenses due to being a public company, including legal and compliance costs [100]. - Management does not anticipate needing to raise additional funds following the initial public offering to meet operational expenditures [105]. Business Development - The company has not selected any business combination target and has not initiated substantive discussions with potential targets [99]. Underwriting and Proceeds - The underwriters exercised an over-allotment option, generating additional gross proceeds of $45.0 million from the sale of 4,500,000 Units at an offering price of $10.00 per Unit [109]. - The total cash underwriting discount paid to underwriters was $6.9 million, with an additional deferred underwriting commission of approximately $12.1 million [110]. Uncertainties - The financial statements do not include adjustments for potential impacts from geopolitical events or health crises, indicating uncertainty in future performance [107].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) | Cayman Islands | 001-39706 | 87-2010879 | | --- | --- | --- | | (State or other jurisdiction ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 216 East ...

Financial Performance - For the three months ended June 30, 2022, the company reported a net income of $1,218,156, which included general and administrative expenses of $393,858 and net gains from derivative liabilities and marketable securities of $1,611,014[116] - For the six months ended June 30, 2022, the company achieved a net income of $6,875,640, with general and administrative expenses totaling $580,730 and net gains from derivative liabilities and marketable securities amounting to $7,456,370[117] Cash and Working Capital - As of June 30, 2022, the company had cash of $605,283 and working capital of $445,033[118] - Management believes that the current working capital and borrowing capacity will be sufficient to meet needs through the completion of a business combination or one year from the filing date[120] - The company has no outstanding amounts under any working capital loans as of June 30, 2022[119] Business Operations - The company has not generated any operating revenues to date and will only do so after completing its initial business combination[114] - The company may need to raise additional funds if the costs of identifying a target business exceed current estimates[121] Public Company Costs - The company expects to incur significantly increased expenses due to being a public company, including legal, financial reporting, and compliance costs[114] COVID-19 Impact - Management continues to evaluate the impact of the COVID-19 pandemic, but the specific impact remains uncertain as of the date of the financial statements[122] Underwriting Activities - The underwriters exercised an over-allotment option on October 8, 2021, purchasing an additional 4,500,000 Units at an offering price of $10.00 per Unit, generating gross proceeds of $45.0 million[125]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ENPHYS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40879 87-2010879 (State or other jurisdiction of incorporation or organization) 216 East 45th Street 13th Floor New York, NY 10017 (Address of principal exec ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enphys Acquisition Corp. (Exact name of registrant as specified in its charter) | Cayman Islands | 001-39706 | 87-2010879 | | --- | --- | --- | | (State or other jurisdiction ...